FNY Managed Accounts’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

FNY Managed Accounts's SLXP Position: Q2 2015 in Review

FNY Managed Accounts sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 180,357 shares — an estimated $31.2M sold.

FNY Managed Accounts first reported a position in SLXP in Q3 2014 and held it in 2 quarters. The position peaked at $31.2M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

• FNY Managed Accounts reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
• FNY Managed Accounts sold 180,357 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $31.2M.
• FNY Managed Accounts first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q3 2014 and held it in 2 quarters.
• FNY Managed Accounts's SALIX PHARMACEUTICALS LTD DEL position peaked at $31.2M in Q1 2015.
• 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on FNY Managed Accounts's 13F filing for Q2 2015, filed 30 Jul 2015.